Which hedge funds own MEDP? MEDPACE HLDGS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
10 of the hedge funds tracked by WhaleCreep disclosed a position in MEDP (MEDPACE HLDGS INC) in their Q2 2026 13F filings, worth $950.9m in total. The largest holder by portfolio weight is Giverny Capital at 4.5% of its book. 1 manager opened a new position this quarter: Brevan Howard Capital Management. 1 exited: Tudor Investment.
10tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold MEDP? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Giverny Capital | Q2 2026 | 4.5% | $134.5m | 253,931 | -1% | reduced |
| Vulcan Value Partners | Q2 2026 | 2.3% | $75.1m | 141,743 | -30% | reduced |
| Baillie Gifford | Q2 2026 | 0.4% | $344.1m | 473,211 | -6% | reduced |
| Renaissance Technologies LLC | Q2 2026 | 0.3% | $220.1m | 415,588 | -18% | reduced |
| Fundsmith | Q2 2026 | 0.2% | $27.7m | 52,372 | -16% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $124.2m | 234,537 | -46% | reduced |
| Bridgewater Associates | Q2 2026 | 0.0% | $8.3m | 15,605 | -62% | reduced |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $1.5m | 2,773 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $15.5m | 29,182 | 196% | added |
| Ancora Advisors | Q2 2026 | 0.0% | $22.2k | 42 | 0% | held |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Tudor Investment | 0.3% | $4.2m |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| Bares Capital Management | Q3 2025 | 5.3% |
How has hedge fund ownership of MEDP changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 10 | $950.9m |
| Q1 2026 | 12 | $1.0bn |
| Q4 2025 | 10 | $805.5m |
| Q3 2025 | 11 | $946.7m |
| Q2 2025 | 10 | $671.1m |
| Q1 2025 | 9 | $542.9m |
| Q4 2024 | 8 | $505.7m |
| Q3 2024 | 7 | $420.4m |
| Q2 2024 | 9 | $512.7m |
| Q1 2024 | 8 | $337.9m |
| Q4 2023 | 7 | $166.5m |
| Q3 2023 | 6 | $141.6m |
| Q2 2023 | 4 | $104.5m |
| Q1 2023 | 5 | $103.0m |
| Q4 2022 | 4 | $77.8m |
| Q3 2022 | 3 | $106.1m |
Counts every tracked manager that disclosed MEDP in that quarter's filing, including managers that have since stopped filing.